Genetic Analysis AS (NGM: GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK0.465
-0.025 (-5.10%)
At close: Dec 23, 2024
Genetic Analysis AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 13.51 | 14.15 | 11.16 | 6.8 | 5.78 | 7.29 | Upgrade
|
| Other Revenue | 6.2 | 9.02 | 9.58 | 6.58 | 1.76 | 3.76 | Upgrade
|
| Revenue | 19.71 | 23.16 | 20.75 | 13.38 | 7.54 | 11.05 | Upgrade
|
| Revenue Growth (YoY) | -12.25% | 11.65% | 55.08% | 77.51% | -31.81% | 103.93% | Upgrade
|
| Cost of Revenue | 3.68 | 4.43 | 3.91 | 1.28 | 1.03 | 1.73 | Upgrade
|
| Gross Profit | 16.03 | 18.73 | 16.84 | 12.1 | 6.51 | 9.32 | Upgrade
|
| Selling, General & Admin | 17.87 | 20.72 | 22.31 | 20.39 | 14.68 | 12.32 | Upgrade
|
| Other Operating Expenses | 13.08 | 16.36 | 17.88 | 16.05 | 7.8 | 8.04 | Upgrade
|
| Operating Expenses | 36.17 | 42.66 | 45.02 | 40.97 | 27.28 | 22.85 | Upgrade
|
| Operating Income | -20.13 | -23.92 | -28.18 | -28.87 | -20.77 | -13.53 | Upgrade
|
| Interest Expense | -0.72 | -0.25 | -0.12 | -0.13 | -0.21 | -0.2 | Upgrade
|
| Interest & Investment Income | 0.34 | 0.36 | 0.03 | - | 0.03 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | 0.09 | -0 | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | -20.42 | -23.73 | -28.27 | -29.01 | -20.95 | -13.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | -0.09 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -1.4 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.22 | 6.78 | Upgrade
|
| Pretax Income | -20.51 | -23.82 | -28.27 | -29.01 | -22.14 | -6.94 | Upgrade
|
| Net Income | -20.51 | -23.82 | -28.27 | -29.01 | -22.14 | -6.94 | Upgrade
|
| Net Income to Common | -20.51 | -23.82 | -28.27 | -29.01 | -22.14 | -6.94 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 38 | 25 | 25 | 17 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 38 | 25 | 25 | 17 | 11 | Upgrade
|
| Shares Change (YoY) | 108.50% | 53.53% | 0.07% | 45.72% | 49.90% | - | Upgrade
|
| EPS (Basic) | -0.39 | -0.62 | -1.13 | -1.16 | -1.29 | -0.61 | Upgrade
|
| EPS (Diluted) | -0.39 | -0.62 | -1.13 | -1.16 | -1.29 | -0.61 | Upgrade
|
| Free Cash Flow | -16.44 | -17.38 | -19.69 | -27.7 | -6.58 | -6.44 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.45 | -0.79 | -1.11 | -0.38 | -0.56 | Upgrade
|
| Gross Margin | 81.35% | 80.87% | 81.17% | 90.42% | 86.37% | 84.35% | Upgrade
|
| Operating Margin | -102.13% | -103.28% | -135.84% | -215.80% | -275.56% | -122.41% | Upgrade
|
| Profit Margin | -104.06% | -102.82% | -136.28% | -216.80% | -293.70% | -62.76% | Upgrade
|
| Free Cash Flow Margin | -83.42% | -75.02% | -94.88% | -207.07% | -87.30% | -58.31% | Upgrade
|
| EBITDA | -20.36 | -23.79 | -28 | -28.7 | -20.57 | -13.43 | Upgrade
|
| EBITDA Margin | -103.29% | -102.69% | -134.95% | -214.56% | -273.00% | -121.52% | Upgrade
|
| D&A For EBITDA | -0.23 | 0.14 | 0.19 | 0.17 | 0.19 | 0.1 | Upgrade
|
| EBIT | -20.13 | -23.92 | -28.18 | -28.87 | -20.77 | -13.53 | Upgrade
|
| EBIT Margin | -102.13% | -103.28% | -135.84% | -215.80% | -275.56% | -122.41% | Upgrade
|
| Revenue as Reported | 19.71 | 23.16 | 20.75 | 13.38 | 7.75 | 17.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.